Dosimetric Analysis with Intensity-modulated Radiation Therapy for Central Nervous System Irradiation in Patients with Brain Cancer Compared with Three-dimensional Conformal Radiation Therapy Treatment

Authors

DOI:

https://doi.org/10.25156/ptj.v9n2y2019.pp50-54

Keywords:

Brain cancer, Intensity-modulated radiation therapy, Radiotherapy, Reduce dose, Three dimensional conformal radiation therapy

Abstract

Intensity-modulated radiation therapy (IMRT) was put as the development of three-dimensional conformal radiation therapy (3D-CRT). The purpose of the present study is to compare the dosimetric analysis of two techniques of radiotherapy (IMRT) and 3D-CRT, which include target volume and organ at risk for both plans. The present study enrolled that nine patients with different types of brain cancer which previously irradiated from November 2018 to May 2019 were selected in Zhianawa Cancer Center in Sulaymaniyah; all cases were planned again by both techniques 3D-CRT and IMRT. IMRT planning provides reducing the dose of both right and left optic nerve mean dose for right optic nerve 13.70 Gy and left 14.93 Gy compared with the 3D-CRT plan (right optic nerve 23.54 Gy and left 19.13 Gy). P = 0.2 for the right optic nerve and P = 0.56 for the left optic nerve were statistically significant. IMRT plan reduces dose to the optic chiasm compared to 3D-CRT plan, the mean dose of optic chiasm for IMRT was 33.37 Gy relative to 3D-CRT which was 34.28 Gy and P = 0.92. IMRT plan was better than 3D-CRT for many organs at risk, especially for optic chiasm and both optic nerve deliver less dose than 3D-CRT.

Downloads

Download data is not yet available.

References

Al Zayat, D. M., E. M. Attalla, H. S. Abouelenein, Y. M. Elkem and W. Khalil. 2014. Dosimetric comparison of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with brain tumors. Open J. Radiol. 4(01): 85.

Bentzen, S. M. 2005. Radiation therapy: Intensity modulated, image guided, biologically optimized and evidence based. Radiother. Oncol. 77(3): 227-230.

Bhatnagar, A. K., E. Brandner, D. Sonnik, A. Wu, S. Kalnicki, M. Deutsch and D. E. Heron. 2006. Intensity modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when compared to conventional tangential fields for primary breast irradiation. Breast Cancer Res. Treat. 96(1): 41-46.

Bortfeld, T. 2006. IMRT: A review and preview. Phys. Med. Biol. 51(13): R363.

Burnet, N. G., S. J. Thomas, K. E. Burton and S. J. Jefferies. 2004. Defining the tumour and target volumes for radiotherapy. Cancer Imaging. 4: 153-161.

Chan, M. D. 2015. Recent technical advances and indications for radiation therapy in low-grade glioma. Semin. Radiat. Oncol. 25: 189-196.

Chui, C. S., M. F. Chan, E. Yorke, S. Spirou and C. C. Ling. 2001. Delivery of intensity-modulated radiation therapy with a conventional multileaf collimator: Comparison of dynamic and segmental methods. Med. Phys. 28(12): 2441-2449.

Feuvret, L., G. Noël, J. J. Mazeron and P. Bey. 2006. Conformity index: A review. Int. J. Radiat. Oncol. Biol. Phys. 64(2): 333-342.

Fontenot, J. D., A. K. Lee and W. D. Newhauser. 2009. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int. J. Radiat. Oncol. Biol. Phys.

(2): 616-622.

Foroudi, F., L. Wilson, M. Bressel, A. Haworth, C. Hornby, D. Pham, J. Cramb, S. Gill, K. H. Tai and T. Kron. 2012. A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer. Radiat. Oncol. 7(1): 111.

Ghosh-Laskar, S., P. H. Yathiraj, D. Dutta, V. Rangarajan, N. Purandare, T. Gupta, A. Budrukkar, V. Murthy, S. Kannan and J. P. Agarwal. 2016. Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensitymodulated radiotherapy in head and neck squamous cell carcinoma: Long-term results. Head Neck. 38(S1): E1481-E1487.

Giglio, P. and M. R. Gilbert. 2010. Neurologic complications of cancer and its treatment. Curr. Oncol. Rep. 12(1): 50-59.

Gong, Y., J. Wang, S. Bai, X. Jiang and F. Xu. 2008. Conventionallyfractionated image-guided intensity modulated radiotherapy (IG-IMRT): A safe and effective treatment for cancer spinal metastasis. Radiat. Oncol. 3(1): 11.

Goyal, S., A. Cohler, J. Camporeale, V. Narra and N. J. Yue. 2008. Intensity-modulated radiation therapy for orbital lymphoma. Radiat. Med. 26(10): 573-581.

Guckenberger, M., F. Pohl, K. Baier, J. Meyer, D. Vordermark and M. Flentje. 2006. Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer. Radiother. Oncol. 79(1): 59-64.

Heron, D. E., K. Gerszten, R. N. Selvaraj, G. C. King, D. Sonnik, H. Gallion, J. Comerci, R. P. Edwards, A. Wu and R. S. Andrade. 2003. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: A comparative dosimetric study of dose volume histograms. Gynecol. Oncol.

(1): 39-45.

ICRU. 1999. Prescribing, Recording and Reporting Photon Beam Therapy. Report 50. International Commission on Radiation Units and Measurements, Bethesda, MD.

Kortmann, R. D., B. Timmermann, R. E. Taylor, G. Scarzello, L. Plasswilm, F. Paulsen, B. Jeremic, A. K. Gnekow, K. Dieckmann and S. Kay. 2003. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Strahlenther. Onkol. 179(8): 509-520.

Krasin, M. J., A. M. Davidoff, X. Xiong, S. Wu, C. H. Hua, F. Navid, C. Rodriguez-Galindo, B. N. Rao, K. A. Hoth and M. D. Neel. 2010. Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma. Int. J. Radiat. Oncol. Biol. Phys. 76(3): 874-878.

Kuang, W. L., Q. Zhou and L. F. Shen. 2012. Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma. Clin. Transl. Oncol.14(10): 783-790.

Kumar, S. S., R. Holla, P. Sukumar, S. Padmanaban and N. Vivekanandan. 2013. Treatment planning and dosimetric comparison study on two different volumetric modulated arc therapy delivery techniques. Rep. Pract. Oncol. Radiother. 18(2): 87-94.

Lin, A., H. M. Kim, J. E. Terrell, L. A. Dawson, J. A. Ship and A. Eisbruch. 2003. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int. J. Radiat. Oncol. Biol. Phys. 57(1): 61-70.

Moret, J. A., O. Koelbl and L. Bogner. 2009. Quasi-IMAT technique and secondary cancer risk in prostate cancer. Strahlenther. Onkol. 185(4): 248-253.

Navarria, P., G. Reggiori, F. Pessina, A. M. Ascolese, S. Tomatis, P. Mancosu, F. Lobefalo, E. Clerici, E. Lopci and A. Bizzi. 2014. Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy lanning in patients with high grade glioma. Radiother. Oncol. 112(3): 425-429.

Nutting, C. M., J. P. Morden, K. J. Harrington, T. G. Urbano, S. A. Bhide, C. Clark, E. A. Miles, A. B. Miah, K. Newbold and M. Tanay. 2011. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet Oncol. 12(2): 127-136.

Scott-Brown, M., A. Miah, K. Harrington and C. Nutting. 2010. Evidencebased review: Quality of life following head and neck intensitymodulated radiotherapy. Radiother. Oncol. 97(2): 249-257.

Spirou, S. V. and C. S. Chui. 1998. A gradient inverse planning algorithm with dose-volume constraints. Med. Phys. 25(3): 321-333.

Sun, X., S. Su, C. Chen, F. Han, C. Zhao, W. Xiao, X. Deng, S. Huang, C. Lin and T. Lu. 2014. Long-term outcomes of intensitymodulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities. Radiother. Oncol. 110(3): 398-403.

Tejpal, G., A. Jaiprakash, B. Susovan, S. Ghosh-Laskar, V. Murthy and A. Budrukkar. 2010. IMRT and IGRT in head and neck cancer: Have we delivered what we promised? Indian J. Surg. Oncol. 1(2): 166-185.

Wu, Q., R. Mohan, M. Morris, A. Lauve and R. Schmidt-Ullrich. 2003. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: Dosimetric results. Int. J. Radiat. Oncol. Biol. Phys. 56(2): 573-585.

Xie, X., S. Ouyang, H. Wang, W. Yang, H. Jin, B. Hu and L. Shen. 2014. Dosimetric comparison of left-sided whole breast irradiation with 3D-CRT, IP-IMRT and hybrid IMRT. Oncol. Rep. 31: 2195-2205.

Yoon, M., S. Y. Park, D. Shin, S. B. Lee, H. R. Pyo, D. Y. Kim and K. H. Cho. 2007. A new homogeneity index based on statistical analysis of the dose-volume histogram. J. Appl. Clin. Med. Phys. 8(2): 9-17.

Zelefsky, M. J., Z. Fuks, M. Hunt, Y. Yamada, C. Marion, C. C. Ling, H. Amols, E. S. Venkatraman and S. A. Leibel. 2002. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys. 53(5): 1111-1116.

Zhou, Q., Y. He, Y. Zhao, Y. Wang, W. Kuang and L. Shen. 2017. A study of 358 cases of locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiation therapy: Improving the seventh edition of the American joint committee on cancer T-staging system. Biomed Res. Int. 2017;2017: 1419676.

Zwahlen, D. R., J. D. Ruben, P. Jones, F. Gagliardi, J. L. Millar and U. Schneider. 2009. Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 74(2): 539-545.

Published

2019-12-01

How to Cite

Omer, N. S., & Ali, R. T. (2019). Dosimetric Analysis with Intensity-modulated Radiation Therapy for Central Nervous System Irradiation in Patients with Brain Cancer Compared with Three-dimensional Conformal Radiation Therapy Treatment. Polytechnic Journal, 9(2), 50-54. https://doi.org/10.25156/ptj.v9n2y2019.pp50-54

Issue

Section

Research Articles